Qin, Yan
Song, Yongping
Wang, Dong
Bai, Ou
Feng, Jifeng
Sun, Xiuhua
Qiu, Lihua
Yang, Jianmin
Yang, Yu
Wang, Zhao
Hu, Jianda
Wang, Huaqing
Su, Hang
Jin, Zhengming
Qian, Wenbin
Jin, Chuan
Zhang, Mingzhi
Yu, Ding
Liu, Li
Chen, Guoan
Li, Yarong
Sun, Tao
Jin, Jie
Bao, Huizheng
Du, Xin
Zhou, Hui
Fu, Gan
Shi, Yuankai
Article History
Received: 12 July 2023
Accepted: 13 January 2024
First Online: 24 January 2024
Declarations
:
: The protocol was developed by the sponsor of the study, Shanghai Henlius Biotech, Inc. The study protocol was reviewed and approved by the relevant independent ethics committee at each participating study centre. Written informed consent was obtained from all study participants prior to screening. Data were collected by the site investigators who vouch for the completeness and accuracy of the data and the fidelity of the trial to the protocol. The sponsor analysed the data. The study was conducted in accordance with the Declaration of Helsinki, Guideline for Good Clinical Practice, and applicable national and local regulations for clinical trials.
: Not applicable.
: The authors declare no competing interests.